title: The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile?
authors.forename: P
authors.initials: P
authors.lastname: Dreger
authors.forename: M
authors.initials: M
authors.lastname: Ritgen
authors.forename: S
authors.initials: S
authors.lastname: Böttcher
authors.forename: N
authors.initials: N
authors.lastname: Schmitz
authors.forename: M
authors.initials: M
authors.lastname: Kneba
mesh_terms: D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000628:therapy*; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000628:therapy*; D011379:Prognosis; D012074:Remission Induction; D033581:Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods